Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Nash

Showing results (11-20 of 248) with videos related to

Pageof 25
Sort By:
Postgraduate Medicine|April 1, 1983
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four casesD T Nash
Clinical Cardiology|November 1, 1990
Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolismD T Nash
Journal of Medicine|January 1, 1980
Gemfibrozil--a new lipid lowering agentD T Nash
JAMA|March 21, 2002
Insulin resistance, ADMA levels, and cardiovascular diseaseDavid T Nash
The American Journal of Cardiology|February 28, 2002
Need for a moratorium on percutaneous transluminal coronary angioplasty in stable coronary artery diseaseDavid T Nash
Southern Medical Journal|April 27, 2007
Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diureticsDavid T Nash
The American Journal of Cardiology|June 1, 1990
Physician inertia in dealing with hypercholesterolemia discovered during hospitalizationD T Nash
Postgraduate Medicine|November 1, 1986
Clarification of lisinopril coughD T Nash
Postgraduate Medicine|July 1, 1986
Lisinopril coughD T Nash
The American Journal of Cardiology|February 15, 1986
Risk factors and progression of coronary artery narrowingD T Nash
Pageof 25

Showing results (11-20 of 248) with videos related to

Sort By:
Pageof 25
Postgraduate Medicine|April 1, 1983
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four casesD T Nash
Clinical Cardiology|November 1, 1990
Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolismD T Nash
Journal of Medicine|January 1, 1980
Gemfibrozil--a new lipid lowering agentD T Nash
JAMA|March 21, 2002
Insulin resistance, ADMA levels, and cardiovascular diseaseDavid T Nash
The American Journal of Cardiology|February 28, 2002
Need for a moratorium on percutaneous transluminal coronary angioplasty in stable coronary artery diseaseDavid T Nash
Southern Medical Journal|April 27, 2007
Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diureticsDavid T Nash
The American Journal of Cardiology|June 1, 1990
Physician inertia in dealing with hypercholesterolemia discovered during hospitalizationD T Nash
Postgraduate Medicine|November 1, 1986
Clarification of lisinopril coughD T Nash
Postgraduate Medicine|July 1, 1986
Lisinopril coughD T Nash
The American Journal of Cardiology|February 15, 1986
Risk factors and progression of coronary artery narrowingD T Nash
Pageof 25